People · Operator
Named in public records as an officer, director or promoter · active 2018–2023 · Biotechnology, Other Technology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Rain Therapeutics Inc. | — | Biotechnology | Series C | $92.0M | $2.8B | 2020 |
| CiVi Biopharma Holdings, Inc. | — | Biotechnology | Series C | $76.5M | $971.2M | 2018 |
| Switchbridge, LLC | — | Other Technology | Pre-Seed | $100K | $939K | 2023 |
Aaron Davis at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Aaron Davis on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Franklin Berger | 1 | 7 |
| Shalom Jacobovitz | 1 | 3 |
| Gorjan Hrustanovic | 1 | 3 |
| Carole Nuechterlein | 1 | 2 |
| Peter Radovich | 1 | 2 |
| Matthew Pietras | 1 | 2 |
| Christopher Fuglesang | 1 | 1 |
| Henrik Oerum | 1 | 1 |
| Tran Nguyen | 1 | 1 |
| Avanish Vellanki | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.